Yves-Jacques Schneider is emeritus full professor from the UCLouvain. After a Ph.D. in cell biochemistry (1977) and a thèse d’agrégation de l’enseignement supérieur (1983) in cell pharmacology at the de Duve Institute (ICP at that time), from 1988 et 2017, he headed the laboratory of cellular, nutritional and toxicological biochemistry in Louvain-la-Neuve. From 2013 to 2017, he was the chairman of the Institute of Life Science (now Louvain Institute of biomolecular Science and technology).
From 1984 to 2017, he taught metabolism, cell biology, pharmacology and cell bioengineering to various students in Louvain-la-Neuve and supervised more than 30 Ph.D. thesis. He participated to numerous academic and industrial research projects and has been involved in several startup companies. He is currently CSO and member of the board of directors of a nanotechnology SME, it4ip.
His research activities aimed at better understanding, at the cellular and molecular levels, several physio-pathological processes, always keeping in mind potential applications. The animal cell technologies were always the most predominant tool all along his scientific career. A special focus was on the development of sophisticated cell culture systems and, in particular, in vitro models of the intestinal mucosa to investigate e.g. on transport of drugs, nutrients and xenobiotics, as well as inflammation processes.